Ruellan, Anne-Lise
25  results:
Search for persons X
?
2

Iatrogénie et syndromes de Cushing:

Ruellan, Anne-Lise ; Boels, David
Actualités Pharmaceutiques.  58 (2019)  585 - p. 28-32 , 2019
 
?
5

Safety and Efficacy of Ceftaroline in Neonates With Staphyl..:

Callies, Arnaud ; Martin-Perceval, Lise ; Crémet, Lise...
info:eu-repo/semantics/altIdentifier/doi/10.1097/INF.0000000000004023.  , 2023
 
?
6

Safety and Efficacy of Ceftaroline in Neonates With Staphyl..:

Callies, Arnaud ; Martin-Perceval, Lise ; Crémet, Lise...
info:eu-repo/semantics/altIdentifier/doi/10.1097/INF.0000000000004023.  , 2023
 
?
7

Safety and Efficacy of Ceftaroline in Neonates With Staphyl..:

Callies, Arnaud ; Martin-Perceval, Lise ; Crémet, Lise...
info:eu-repo/semantics/altIdentifier/doi/10.1097/INF.0000000000004023.  , 2023
 
?
8

Safety and Efficacy of Ceftaroline in Neonates With Staphyl..:

Callies, Arnaud ; Martin-Perceval, Lise ; Crémet, Lise...
info:eu-repo/semantics/altIdentifier/doi/10.1097/INF.0000000000004023.  , 2023
 
?
9

Safety and Efficacy of Ceftaroline in Neonates With Staphyl..:

Callies, Arnaud ; Martin-Perceval, Lise ; Crémet, Lise...
info:eu-repo/semantics/altIdentifier/doi/10.1097/INF.0000000000004023.  , 2023
 
?
10

Safety and Efficacy of Ceftaroline in Neonates With Staphyl..:

Callies, Arnaud ; Martin-Perceval, Lise ; Crémet, Lise...
info:eu-repo/semantics/altIdentifier/doi/10.1097/INF.0000000000004023.  , 2023
 
?
11

Safety and Efficacy of Ceftaroline in Neonates With Staphyl..:

Callies, Arnaud ; Martin-Perceval, Lise ; Crémet, Lise...
info:eu-repo/semantics/altIdentifier/doi/10.1097/INF.0000000000004023.  , 2023
 
?
12

Safety and Efficacy of Ceftaroline in Neonates With Staphyl..:

Callies, Arnaud ; Martin-Perceval, Lise ; Crémet, Lise...
info:eu-repo/semantics/altIdentifier/doi/10.1097/INF.0000000000004023.  , 2023
 
?
13

Safety and Efficacy of Ceftaroline in Neonates With Staphyl..:

Callies, Arnaud ; Martin-Perceval, Lise ; Crémet, Lise...
info:eu-repo/semantics/altIdentifier/doi/10.1097/INF.0000000000004023.  , 2023
 
1-15